Page last updated: 2024-08-23

bromocriptine and quinagolide

bromocriptine has been researched along with quinagolide in 62 studies

Research

Studies (62)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.61)	18.7374
1990's	38 (61.29)	18.2507
2000's	12 (19.35)	29.6817
2010's	8 (12.90)	24.3611
2020's	3 (4.84)	2.80

Authors

Authors	Studies
Brue, T; Jaquet, P; Morange, I; Pellegrini, I; Priou, A	1
Caruso, E; Colao, A; Di Sarno, A; Di Somma, C; Lombardi, G; Merola, B; Sarnacchiaro, F	1
Brownell, J; Brue, T; Dewailly, D; Enjalbert, A; Gunz, G; Jaquet, P; Morange, I; Pellegrini, I	1
Blackwell, RE	1
Brownell, J; Lappöhn, RE; van de Wiel, HB	1
Chanson, P; Duranteau, L; Horlait, S; Kuhn, JM; Lavoinne, A; Lubetzki, J	1
Brownell, J; Kremer, JA; Rolland, R; van der Heijden, PF	1
Brownell, J; Lamberts, SW; van der Lely, AJ	1
Brownell, J; de Wit, W; Rolland, R; Schoemaker, J; van der Heijden, PF	1
Geyer, G; Knosp, E; Luger, A; Svoboda, T	1
Besser, GM; Froud, AL; Grossman, AB; Touzel, R; Verhelst, JA; Wass, JA	1
Brownell, J; Crottaz, B; Gomez, F; Rey, F; Reymond, MJ; Siegel, RA; Uske, A	1
Philosophe, R; Seibel, MM	1
Brownell, J; Homburg, R; Jacobs, HS; West, C	1
Brownell, J; Kremer, JA; Rolland, R; Schellekens, LA; Thomas, CM; van der Heijden, PF	1
Rasmussen, C	1
Hurley, AM; Kleinberg, DL; Newman, CB	1
Becker, W; Buchfelder, M; Fahlbusch, R; Horvath, E; Kovacs, K; Stefaneanu, L	1
Colao, A; Di Sarno, A; Di Somma, C; Ferone, D; Landi, ML; Merola, B; Nappi, C; Sarnacchiaro, F; Schettini, G; Selleri, A	1
Burke, CW; Vilar, L	1
Chevallier, P; Claustrat, B; Dubray, C; Girod, C; Hooghe-Peters, E; Rousset, B; Trouillas, J	1
Beardwell, CG; O'Halloran, DJ; Razzaq, R; Shalet, SM	1
Barziliai, S; Glaser, B; Nesher, Y	1
Blackard, WG	1
Bakke, S; Bjøro, T; Brownell, J; Djøseland, O; Halse, J; Hansen, E; Jervell, J; Kvistborg, A	1
Attanasio, R; Chiodini, PG; Cozzi, R; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Orlandi, P; Strada, S	1
Assies, J; Bosch, DA; Hofland, LJ; Verhoeff, NP	1
Cerbone, G; Colao, A; Di Sarno, A; Ferone, D; Landi, ML; Lombardi, G; Marzullo, P; Merola, B; Sarnacchiaro, F	1
Webster, J	1
Barlier, A; Brue, T; Enjalbert, A; Jaquet, P; Morange, I; Pellegrini, I	1
Cerbone, G; Cirillo, S; Colao, A; Di Sarno, A; Ferone, D; Lombardi, G; Marzullo, P; Merola, B; Sarnacchiaro, F	1
Jaquet, P	2
De Herder, WW; Hofland, LJ; Kros, MJ; Lamberts, SW; Uitterlinden, P; Van Koetsveld, PM; Van Uffelen, C; Visser-Wisselaar, HA; Waaijers, M; Zuyderwijk, J	1
Colao, A; Di Sarno, A; Di Somma, C; Facciolli, G; Klain, M; Landi, ML; Lombardi, G; Panza, N; Pivonello, R; Salvatore, M	1
Conner, P; Fried, G	1
Crabbé, J; Delgrange, E; Donckier, J	1
Cappa, M; Colao, A; Di Sarno, A; Facciolli, G; Landi, ML; Loche, S; Lombardi, G; Sarnacchiaro, F	1
Colao, A; Di Sarno, A; Di Somma, C; Klain, M; Loche, S; Lombardi, G; Pietrosante, M; Pivonello, R; Salvatore, M	1
Hulting, AL; Melkersson, K	1
Freneau, E; Morange, I; Rohmer, V; Simonetta, C	1
Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R	1
Bankowski, BJ; Zacur, HA	1
Trifonov, I	1
Goadsby, PJ; Levy, MJ; Matharu, MS; Meeran, K; Powell, M	1
Crosignani, PG	1
Bronstein, MD	1
Barlier, A; Jaquet, P	1
Chuang, E; Molitch, ME	1
Mezosi, E; Nemes, O	1
Adamidou, F; Anagnostis, P; Efstathiadou, Z; Karathanassi, E; Kita, M; Polyzos, SA	1
Boutinaud, M; Bruckmaier, RM; Dessauge, F; Lacasse, P; Lollivier, V; Ollier, S	1
Góth, M	1
Beketić-Orešković, L; Ježek, D; Kasum, M; Orešković, S; Pekez, M; Stanić, P; Vrčić, H	1
Chapman, IM; De Sousa, SM; Falhammar, H; Torpy, DJ	1
Hart, RJ; Mourad, S; Tang, H; Zhai, SD	1
Beckers, A; Bonneville, JF; Brue, T; Castinetti, F; Cuny, T; Dufour, H; Eroukhmanoff, J; Potorac, I; Tejedor, I; Touraine, P; Weryha, G	1
Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G	1
Hart, RJ; Mourad, SM; Tang, H; Wang, A; Zhai, SD	1
Auriemma, RS; Colao, A; Negri, M; Patalano, R; Pirchio, R; Pivonello, C; Pivonello, R	1
Huang, Q; Li, M; Tan, J; Zeng, Y; Zhou, W; Zou, Y	1

Reviews

21 review(s) available for bromocriptine and quinagolide

Article	Year
Hyperprolactinemia. Evaluation and management. Endocrinology and metabolism clinics of North America, 1992, Volume: 21, Issue:1 Topics: Aminoquinolines; Animals; Bromocriptine; Dopamine Agents; Female; Humans; Hyperprolactinemia; Infertility; Ovary; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
Novel approaches to the management of hyperprolactinemia. Current opinion in obstetrics & gynecology, 1991, Volume: 3, Issue:3 Topics: Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Humans; Hyperprolactinemia; Pergolide	1991
New drugs for hyperprolactinaemia. Drug and therapeutics bulletin, 1995, Volume: 33, Issue:9 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Clinical Trials as Topic; Ergolines; Hormone Antagonists; Humans; Hyperprolactinemia	1995
A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug safety, 1996, Volume: 14, Issue:4 Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Male; Pregnancy	1996
[Quinagolide and macroprolactinomas a progress?]. Annales d'endocrinologie, 1997, Volume: 58, Issue:2 Topics: Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	1997
Hyperprolactinemia; etiology, diagnosis and treatment alternatives. Acta obstetricia et gynecologica Scandinavica, 1998, Volume: 77, Issue:3 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pergolide; Prolactin; Receptors, Prolactin	1998
Dopamine receptor agonists for treating prolactinomas. Expert opinion on investigational drugs, 2002, Volume: 11, Issue:6 Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma	2002
Dopamine agonist therapy for hyperprolactinemia. Clinical obstetrics and gynecology, 2003, Volume: 46, Issue:2 Topics: Aminoquinolines; Benzothiazoles; Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Ergoloid Mesylates; Female; Humans; Hyperprolactinemia; Indoles; Pergolide; Pramipexole; Thiazoles	2003
[Prolactinoma and pregnancy]. Akusherstvo i ginekologiia, 2004, Volume: 43 Suppl 2 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	2004
Current treatment issues in female hyperprolactinaemia. European journal of obstetrics, gynecology, and reproductive biology, 2006, Apr-01, Volume: 125, Issue:2 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Pregnancy; Prolactinoma	2006
Prolactinomas and pregnancy. Pituitary, 2005, Volume: 8, Issue:1 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	2005
Quinagolide--a valuable treatment option for hyperprolactinaemia. European journal of endocrinology, 2006, Volume: 154, Issue:2 Topics: Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Patient Compliance	2006
[Treatment of pituitary adenomas]. Orvosi hetilap, 2009, Sep-27, Volume: 150, Issue:39 Topics: Acromegaly; ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Aminoquinolines; Bromocriptine; Cushing Syndrome; Dopamine Agonists; Female; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Hypophysectomy; Incidental Findings; Male; Pituitary Hormones; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Radiosurgery; Receptors, Somatotropin; Somatostatin; Thyrotropin	2009
New developments on the galactopoietic role of prolactin in dairy ruminants. Domestic animal endocrinology, 2012, Volume: 43, Issue:2 Topics: Aminoquinolines; Animals; Bromocriptine; Cattle; Dopamine Agonists; Female; Lactation; Lactose; Milk; Milk Proteins; Prolactin	2012
[Drug therapy for acromegaly]. Orvosi hetilap, 2013, Sep-29, Volume: 154, Issue:39 Topics: Acromegaly; Aminoquinolines; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Interdisciplinary Communication; Membrane Proteins; Octreotide; Patient Care Team; Peptides, Cyclic; Pituitary Neoplasms; Somatostatin	2013
Dopamine agonists in prevention of ovarian hyperstimulation syndrome. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:12 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction	2014
Dopamine agonists for preventing ovarian hyperstimulation syndrome. The Cochrane database of systematic reviews, 2016, 11-30, Volume: 11 Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted	2016
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome Acta clinica Croatica, 2017, Volume: 56, Issue:1 Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate	2017
Dopamine agonists for preventing ovarian hyperstimulation syndrome. The Cochrane database of systematic reviews, 2021, 04-14, Volume: 4 Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fertilization in Vitro; Humans; Live Birth; Ovarian Hyperstimulation Syndrome; Placebos; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Sperm Injections, Intracytoplasmic	2021
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms. Frontiers in endocrinology, 2021, Volume: 12 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aminoquinolines; beta-Arrestins; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Filamins; Growth Hormone-Secreting Pituitary Adenoma; Humans; Lisuride; MicroRNAs; Pergolide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2	2021
The efficacy and safety of quinagolide in hyperprolactinemia treatment: A systematic review and meta-analysis. Frontiers in endocrinology, 2023, Volume: 14 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Drug-Related Side Effects and Adverse Reactions; Humans; Hyperprolactinemia; Pituitary Neoplasms	2023

Trials

15 trial(s) available for bromocriptine and quinagolide

Article	Year
The effect of two dopaminergic drugs on menstrual function and psychological state in hyperprolactinemia. Fertility and sterility, 1992, Volume: 58, Issue:2 Topics: Adult; Amenorrhea; Aminoquinolines; Bromocriptine; Depression; Dopamine Agents; Female; Humans; Hyperprolactinemia; Menstruation; Oligomenorrhea; Prolactin; Prospective Studies; Psychological Tests	1992
Lactation inhibition by the dopamine agonist CV 205-502. British journal of obstetrics and gynaecology, 1991, Volume: 98, Issue:3 Topics: Administration, Oral; Aminoquinolines; Blood Coagulation Tests; Bromocriptine; Dopamine Agents; Drug Administration Schedule; Electrocardiography; Female; Humans; Lactation; Pilot Projects; Postpartum Period; Pregnancy; Prolactin; Pulse	1991
The efficacy and tolerability of CV 205-502 (a nonergot dopaminergic drug) in macroprolactinoma patients and in prolactinoma patients intolerant to bromocriptine. The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:5 Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Tolerance; Female; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors	1991
CV 205-502, a new dopamine agonist, versus bromocriptine in the treatment of hyperprolactinaemia. European journal of obstetrics, gynecology, and reproductive biology, 1991, Jul-01, Volume: 40, Issue:2 Topics: Adolescent; Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Double-Blind Method; Drug Evaluation; Drug Tolerance; Female; Galactorrhea; Humans; Hyperprolactinemia; Menstrual Cycle; Middle Aged; Patient Compliance; Prolactin	1991
[Treatment of prolactinoma with a new dopamine agonist]. Deutsche medizinische Wochenschrift (1946), 1991, Aug-16, Volume: 116, Issue:33 Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors	1991
Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study. Acta endocrinologica, 1991, Volume: 125, Issue:4 Topics: Adult; Aminoquinolines; Blood Pressure; Bromocriptine; Dopamine Agents; Double-Blind Method; Drug Administration Schedule; Female; Hormones; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin; Time Factors	1991
A double-blind study comparing a new non-ergot, long-acting dopamine agonist, CV 205-502, with bromocriptine in women with hyperprolactinaemia. Clinical endocrinology, 1990, Volume: 32, Issue:5 Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Double-Blind Method; Female; Humans; Hyperprolactinemia; Iodine Radioisotopes; Menstruation; Middle Aged; Prolactin; Radioimmunoassay; Randomized Controlled Trials as Topic	1990
Hyperprolactinaemia--a clinical study with special reference to long-term follow-up, treatment with dopamine agonists, and pregnancy. Upsala journal of medical sciences, 1990, Volume: 95, Issue:1 Topics: Adolescent; Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Menstruation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Radiography; Sella Turcica	1990
Effect of CV 205-502 in hyperprolactinaemic patients intolerant of bromocriptine. Clinical endocrinology, 1989, Volume: 31, Issue:4 Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Drug Evaluation; Drug Tolerance; Female; Humans; Hyperprolactinemia; Menstruation Disturbances; Middle Aged; Prolactin	1989
Positive response to compound CV 205-502 in hyperprolactinemic patients resistant to or intolerant of bromocriptine. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1994, Volume: 8, Issue:3 Topics: Administration, Oral; Adult; Aminoquinolines; Bromocriptine; Delayed-Action Preparations; Dopamine Agonists; Drug Resistance; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors; Tomography, X-Ray Computed	1994
Quinagolide efficacy and tolerability in hyperprolactinaemic patients who are resistant to or intolerant of bromocriptine. Clinical endocrinology, 1994, Volume: 41, Issue:6 Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Drug Tolerance; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prospective Studies	1994
Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502. The Journal of reproductive medicine, 1994, Volume: 39, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome	1994
Long-term treatment of macroprolactinomas with CV 205-502. Acta endocrinologica, 1993, Volume: 128, Issue:4 Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Drug Tolerance; Erectile Dysfunction; Estradiol; Female; Humans; Libido; Longitudinal Studies; Male; Menstruation; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone; Visual Fields	1993
Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas. Hormone research, 1995, Volume: 44, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Bromocriptine; Dopamine Agonists; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Reagent Kits, Diagnostic; Tomography, X-Ray Computed	1995
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:3 Topics: Adult; Aminoquinolines; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Male; Middle Aged; Prospective Studies	1998

Other Studies

26 other study(ies) available for bromocriptine and quinagolide

Article	Year
Prolactinomas and resistance to dopamine agonists. Hormone research, 1992, Volume: 38, Issue:1-2 Topics: Adolescent; Adult; Aminoquinolines; Bromocriptine; Child; Drug Resistance; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
Usefulness of CV 205-502 in a case of allergy to ergot-derived drugs. Hormone research, 1992, Volume: 38, Issue:3-4 Topics: Adult; Aminoquinolines; Bromocriptine; Drug Hypersensitivity; Female; Humans; Lisuride; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine. The Journal of clinical endocrinology and metabolism, 1992, Volume: 74, Issue:3 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Resistance; Female; Growth Hormone; Humans; Luteinizing Hormone; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed; Triiodothyronine; Tumor Cells, Cultured	1992
Effect of the new dopaminergic agonist CV 205-502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas. Clinical endocrinology, 1991, Volume: 34, Issue:1 Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Retrospective Studies	1991
CV 205-502 treatment of macroprolactinomas. Journal of endocrinological investigation, 1991, Volume: 14, Issue:9 Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Drug Resistance; Endocrine System Diseases; Female; Galactorrhea; Gonads; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1991
Postpartum return of pituitary and ovarian activity during lactation inhibition with the new dopamine agonist CV 205-502 and during normal lactation. Acta endocrinologica, 1990, Volume: 122, Issue:6 Topics: Aminoquinolines; Bromocriptine; Dopamine Agents; Estradiol; Female; Fertility; Follicle Stimulating Hormone; Humans; Lactation; Luteinizing Hormone; Ovary; Pituitary Gland; Postpartum Period; Prolactin	1990
Prolactin-producing pituitary tumor: resistance to dopamine agonist therapy. Case report. Journal of neurosurgery, 1995, Volume: 82, Issue:5 Topics: Adenoma; Adolescent; Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Resistance; Female; Humans; Microscopy, Electron; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Estrogen; RNA, Messenger	1995
Inhibitory effects of the dopamine agonists quinagolide (CV 205-502) and bromocriptine on prolactin secretion and growth of SMtTW pituitary tumors in the rat. Endocrinology, 1994, Volume: 134, Issue:1 Topics: Aminoquinolines; Animals; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Neoplasm Transplantation; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred WF; Ultrasonography	1994
The effects of CV205-502 in patients with hyperprolactinaemia intolerant and/or resistant to bromocriptine. Hormone research, 1993, Volume: 39, Issue:5-6 Topics: Adult; Amenorrhea; Aminoquinolines; Bromocriptine; Dopamine Agents; Drug Resistance; Drug Tolerance; Female; Galactorrhea; Humans; Hyperprolactinemia; Middle Aged; Pregnancy; Prolactin	1993
Edema--an infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs. The American journal of medicine, 1993, Volume: 94, Issue:4 Topics: Aminoquinolines; Bromocriptine; Dopamine Agents; Edema; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactinoma	1993
CV 205-502 in acromegaly. Acta endocrinologica, 1993, Volume: 128, Issue:5 Topics: Acromegaly; Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Gland; Prolactin; Time Factors	1993
Intracranial dissemination of a macroprolactinoma. Clinical endocrinology, 1993, Volume: 38, Issue:5 Topics: Aminoquinolines; Brain Neoplasms; Bromocriptine; Combined Modality Therapy; Drug Therapy, Combination; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Radiotherapy Dosage; Somatostatin	1993
Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy. European journal of endocrinology, 1996, Volume: 135, Issue:4 Topics: Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Resistance; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma	1996
Effect of different dopaminergic agents in the treatment of acromegaly. The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:2 Topics: Acromegaly; Adult; Aminoquinolines; Bromocriptine; Cabergoline; Delayed-Action Preparations; Dopamine Agonists; Ergolines; Female; Human Growth Hormone; Humans; Male; Middle Aged; Prolactin	1997
Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors. The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:9 Topics: Adenoma; Adenoma, Islet Cell; Aminoquinolines; Bromocriptine; Dopamine Agonists; Endocrine Gland Neoplasms; Hormone Antagonists; Hormones; Humans; Insulinoma; Pancreatic Neoplasms; Pituitary Neoplasms; Prolactinoma; Receptors, Somatostatin; Somatostatin; Tumor Cells, Cultured	1997
Evidence for dopamine agonists in the treatment of acromegaly. The Journal of endocrinology, 1997, Volume: 155 Suppl 1 Topics: Acromegaly; Adenoma; Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Humans; Octreotide; Pituitary Neoplasms; Somatostatin	1997
Late development of resistance to bromocriptine in a patient with macroprolactinoma. Hormone research, 1998, Volume: 49, Issue:5 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1998
Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up. The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:8 Topics: Adolescent; Amenorrhea; Aminoquinolines; Bromocriptine; Child; Dopamine Agonists; Drug Resistance; Female; Follow-Up Studies; Galactorrhea; Growth Disorders; Humans; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Puberty	1998
Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clinical endocrinology, 2000, Volume: 52, Issue:3 Topics: Adolescent; Adult; Aminoquinolines; Analysis of Variance; Biomarkers; Bone Density; Bone Remodeling; Bromocriptine; Cabergoline; Case-Control Studies; Collagen; Collagen Type I; Dopamine Agonists; Ergolines; Female; Femur Neck; Humans; Longitudinal Studies; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Osteoporosis; Peptides; Pituitary Neoplasms; Prolactinoma; Regression Analysis	2000
Prolactin-secreting pituitary adenoma in neuroleptic treated patients with psychotic disorder. European archives of psychiatry and clinical neuroscience, 2000, Volume: 250, Issue:1 Topics: Adult; Aminoquinolines; Antipsychotic Agents; Bipolar Disorder; Bromocriptine; Clozapine; Comorbidity; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Psychoses, Substance-Induced; Psychotic Disorders	2000
Efficacy of quinagolide in resistance to dopamine agonists: results of a multicenter study. Club de l'Hypophyse. Annales d'endocrinologie, 2000, Volume: 61, Issue:5 Topics: Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies	2000
The clinical characteristics of headache in patients with pituitary tumours. Brain : a journal of neurology, 2005, Volume: 128, Issue:Pt 8 Topics: Adenoma; Adult; Aminoquinolines; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Disability Evaluation; Dopamine Agonists; Ergolines; Female; Headache; Humans; Male; Migraine Disorders; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Severity of Illness Index; Somatostatin; Time Factors	2005
Prolactin and autoimmune diseases in humans. Acta bio-medica : Atenei Parmensis, 2007, Volume: 78 Suppl 1 Topics: Aminoquinolines; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Bromocriptine; Cabergoline; Cyclosporine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mice; Mice, Knockout; Penicillamine; Prednisone; Prolactin; Rats; Receptors, Prolactin	2007
Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience. Pituitary, 2012, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prolactinoma; Treatment Outcome; Young Adult	2012
Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. Endocrine, 2017, Volume: 55, Issue:2 Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hypogonadism; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sexual Dysfunction, Physiological	2017
MRI follow-up is unnecessary in patients with macroprolactinomas and long-term normal prolactin levels on dopamine agonist treatment. European journal of endocrinology, 2017, Volume: 176, Issue:3 Topics: Adult; Aminoquinolines; Belgium; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; France; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies	2017